BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31347924)

  • 1. Hybridoma technology: the preferred method for monoclonal antibody generation for
    Zaroff S; Tan G
    Biotechniques; 2019 Sep; 67(3):90-92. PubMed ID: 31347924
    [No Abstract]   [Full Text] [Related]  

  • 2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
    Holzlöhner P; Hanack K
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies as specific tumor therapy agents. Wishful thinking or reality?].
    Gramatzki M; Valerius T
    Internist (Berl); 1997 Nov; 38(11):1055-62. PubMed ID: 9453954
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer.
    Syrigos KN; Deonarian DP; Epenetos AA
    Hybridoma; 1999 Jun; 18(3):219-24. PubMed ID: 10475235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of monoclonal antibody immunoconjugates in cancer therapy.
    Pietersz GA; Krauer K; McKenzie IF
    Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monoclonal antibodies: immunobiotechnologic principles of production and prospects of use].
    Man'ko VM
    Gematol Transfuziol; 1990 Apr; 35(4):4-10. PubMed ID: 2197169
    [No Abstract]   [Full Text] [Related]  

  • 8. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
    Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
    Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridomas and monoclonal antibodies: applications in oncology.
    Zalcberg JR; McKenzie IF
    Aust N Z J Surg; 1982 Aug; 52(4):431-8. PubMed ID: 7052043
    [No Abstract]   [Full Text] [Related]  

  • 10. Mouse monoclonal antibodies against estrogen receptor.
    De Rosa C; Rossi V; Abbondanza C
    Methods Mol Biol; 2014; 1204():165-85. PubMed ID: 25182770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state of the hybridoma technology.
    Pirofski L; Casadevall A; Rodriguez L; Zuckier LS; Scharff MD
    J Clin Immunol; 1990 Nov; 10(6 Suppl):5S-12S; discussion 12S-14S. PubMed ID: 2081790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in clinical immunology.
    Sevier ED; David GS; Martinis J; Desmond WJ; Bartholomew RM; Wang R
    Clin Chem; 1981 Nov; 27(11):1797-806. PubMed ID: 7028317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and Screening of Monoclonal Peptide Antibodies.
    Trier NH; Mortensen A; Schiolborg A; Friis T
    Methods Mol Biol; 2015; 1348():109-26. PubMed ID: 26424268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An overview of antibody therapy against cancer].
    Taniguchi H; Imai K
    Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of monoclonal antibodies for the therapy of cancer.
    Farah RA; Clinchy B; Herrera L; Vitetta ES
    Crit Rev Eukaryot Gene Expr; 1998; 8(3-4):321-56. PubMed ID: 9807699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.
    Smith SA; Crowe JE
    Microbiol Spectr; 2015 Feb; 3(1):AID-0027-2014. PubMed ID: 26104564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybridoma technology for the generation of monoclonal antibodies.
    Zhang C
    Methods Mol Biol; 2012; 901():117-35. PubMed ID: 22723097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of an anti-CD20, single-chain antibody by phage ELISA on fixed cells.
    Schmidt S; Braunagel M; Kürschner T; Little M
    Biotechniques; 1999 Apr; 26(4):697-702. PubMed ID: 10343908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody engineering, a strategy for the development of monoclonal antibodies.
    Schönherr OT; Houwink EH
    Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.